CBD and the changing regulatory landscape for hemp-derived products

Martin J. Hahn and Samantha Dietle will provide an overview of the impact that changes to the Farm Bill will have on the FDA regulation of hemp and hemp-derived ingredients, as well as the Food and Drug Administration’s authority to regulate the use of hemp-derived ingredients in FDA-regulated foods, dietary supplements, and cosmetics.

Delia A. Deschaine will explore the Drug Enforcement Agency’s historical regulation of cannabis-derivatives under the Controlled Substances Act and the unique issues presented by the development of cannabis-derivatives as approved new drugs under the DEA’s and FDA’s authority.

Back To Listing
Loading data